David L. Nelson

Q: What Schools Are Affiliated With David L. Nelson

David L. Nelson is affiliated with the following schools: University of California, Berkeley, Stanford University, Massachusetts Institute of Technology, Baylor College of Medicine, University of Virginia, University of Washington

David L. Nelson's AcademicInfluence.com Rankings

David L. Nelson

Biology

#4413

World Rank

#6582

Historical Rank

#1658

USA Rank

Genetics

#635

World Rank

#719

Historical Rank

#226

USA Rank

biology Degrees

Download Badge

Biology

David L. Nelson's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is David L. Nelson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David L. Nelson is an American human geneticist, currently an associate director at the Intellectual and Developmental Disabilities Research Center , and professor at the Department of Molecular and Human Genetics at Baylor College of Medicine BCM since 1999. Since 2018, he is the director at the Cancer and Cell Biology Ph.D program, and the director of Integrative Molecular and Biomedical Sciences Ph.D since 2015 at BCM.

(See a Problem?)

David L. Nelson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Initial sequencing and analysis of the human genome. (2001) (15222)
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome (1991) (3264)
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox (1991) (2046)
Absence of expression of the FMR-1 gene in fragile X syndrome (1991) (1398)
Evolutionary and Biomedical Insights from the Rhesus Macaque Genome (2007) (1309)
The DNA sequence of the human X chromosome (2005) (1072)
DNA methylation represses FMR-1 transcription in fragile X syndrome. (1992) (694)
Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway (2004) (643)
Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. (1989) (559)
Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti (2000) (531)
A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. (1998) (526)
Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10 (2000) (490)
Length of uninterrupted CGG repeats determines instability in the FMR1 gene (1994) (478)
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase (1992) (440)
X-linked situs abnormalities result from mutations in ZIC3 (1997) (416)
Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome (2005) (399)
Triplet repeat mutations in human disease. (1992) (378)
Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome (1993) (370)
RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTAS (2007) (318)
Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice (2008) (307)
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. (2000) (302)
Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration (2013) (298)
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. (2000) (276)
Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat (1993) (270)
Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island (1996) (255)
Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain (2002) (242)
Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning (2011) (211)
The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo (2006) (192)
Advances in molecular analysis of fragile X syndrome. (1994) (188)
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE (1994) (177)
Fine structure of the human FMR1 gene. (1993) (177)
The Unstable Repeats—Three Evolving Faces of Neurological Disease (2013) (177)
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. (2001) (169)
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. (1996) (161)
Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome (1995) (158)
Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. (1990) (157)
Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. (2001) (154)
Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism (2001) (153)
AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome (2012) (148)
Interruptions in the triplet repeats of SCA1 and FRAXA reduce the propensity and complexity of slipped strand DNA (S-DNA) formation. (1998) (147)
Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. (2004) (142)
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). (2001) (140)
Knockout mouse model for Fxr2: a model for mental retardation. (2002) (138)
Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. (1997) (137)
High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. (1993) (134)
Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. (2007) (130)
Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. (2006) (128)
Alternative splicing in the fragile X gene FMR1. (1993) (122)
Fragile X-related proteins regulate mammalian circadian behavioral rhythms. (2008) (120)
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome (2011) (118)
Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. (1996) (115)
Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. (2009) (109)
Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2. (1996) (108)
Ectopic expression of CGG containing mRNA is neurotoxic in mammals. (2009) (107)
Impaired Conditioned Fear and Enhanced Long-Term Potentiation inFmr2 Knock-Out Mice (2002) (107)
Erratum: Initial sequencing and analysis of the human genome: International Human Genome Sequencing Consortium (Nature (2001) 409 (860-921)) (2001) (106)
Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. (1996) (102)
Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. (1992) (96)
Molecular definition of pericentric inversion breakpoints occurring during the evolution of humans and chimpanzees. (1998) (95)
Haplotype and linkage disequilibrium architecture for human cancer-associated genes. (2002) (92)
Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. (2001) (88)
Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier? (2006) (86)
Report of the sixth international workshop on X chromosome mapping 1995 (1995) (86)
Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. (2001) (84)
Anomalous rapid electrophoretic mobility of DNA containing triplet repeats associated with human disease genes. (1995) (84)
Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene. (2008) (83)
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. (1992) (82)
Frequency and stability of the fragile X premutation. (1994) (80)
Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. (1994) (78)
An integrated physical and genetic map of a 35 Mb region on chromosome Xp22.3-Xp21.3. (1995) (76)
Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. (1998) (75)
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome (2015) (74)
NF-κB signaling and human disease (2001) (74)
Population survey of the human FMR1 CGG repeat substructure suggests biased polarity for the loss of AGG interruptions. (1995) (73)
Molecular and phenotypic variation in patients with severe Hunter syndrome. (1997) (72)
Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo (2016) (71)
130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. (1995) (71)
Ehlers-Danlos syndrome type VIII. (1981) (71)
Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE. (1996) (70)
Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. (2012) (69)
Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. (1997) (69)
FMR1 in global populations. (1996) (68)
The fragile X premutation in carriers and its effect on mutation size in offspring. (1995) (67)
Alternative splicing in the murine and human FXR1 genes. (1999) (67)
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome (2014) (66)
Report of the Fourth International Workshop on human X chromosome mapping 1993 (1993) (66)
NEMO, NFκB signaling and incontinentia pigmenti (2006) (64)
Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. (2004) (64)
Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation (2007) (64)
Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes (2007) (64)
Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. (2000) (63)
LRRK 2 regulates mitochondrial dynamics and function through direct interaction with DLP 1 (2012) (61)
The DNA sequence, annotation and analysis of human chromosome 3 (2006) (60)
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome. (2014) (58)
Trinucleotide repeat instability: when and where? (1993) (57)
A de novo deletion in FMR1 in a patient with developmental delay. (1994) (57)
Trinucleotide repeat expansions in neurological disease (1993) (57)
Alu-primed polymerase chain reaction for regional assignment of 110 yeast artificial chromosome clones from the human X chromosome: identification of clones associated with a disease locus. (1991) (56)
FXR1P But Not FMRP Regulates the Levels of Mammalian Brain-Specific microRNA-9 and microRNA-124 (2011) (56)
The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. (2000) (55)
Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. (2006) (54)
Homeostatic Responses Fail to Correct Defective Amygdala Inhibitory Circuit Maturation in Fragile X Syndrome (2013) (54)
Report of the fifth international workshop on human X chromosome mapping (1994) (53)
A muscle-specific DNase I-like gene in human Xq28. (1995) (53)
Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. (2002) (53)
Positive Selection of a Pre-Expansion CAG Repeat of the Human SCA2 Gene (2005) (52)
Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. (1994) (52)
Evolution of the cryptic FMR1 CGG repeat (1995) (51)
Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. (2007) (50)
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. (2009) (50)
The finished DNA sequence of human chromosome 12 (2006) (49)
NEMO, NFkappaB signaling and incontinentia pigmenti. (2006) (48)
Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene. (2008) (46)
Desmoplakin and Talin2 Are Novel mRNA Targets of Fragile X–Related Protein-1 in Cardiac Muscle (2011) (46)
Direct cloning of human transcripts with HnRNA from hybrid cell lines. (1990) (46)
The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidney. (1995) (43)
A Primate Genome Project Deserves High Priority (2000) (41)
Genome analysis and the human X chromosome. (1992) (40)
The Drosophila FMRP and LARK RNA-Binding Proteins Function Together to Regulate Eye Development and Circadian Behavior (2008) (39)
Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome. (2019) (39)
Genetic variation and evolutionary stability of the FMR1 CGG repeat in six closed human populations. (1996) (38)
NF-kappaB signaling and human disease. (2001) (38)
FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation. (2014) (37)
Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. (2012) (35)
FMR2 function: insight from a mouse knockout model (2003) (35)
Fragile X syndrome in a normal IQ male with learning and emotional problems. (1994) (30)
The Critical Region in Trisomy 21 (2004) (30)
Ca2+ influx across the excitable membrane of behavioural mutants of Paramecium (1976) (30)
MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith–Magenis and fragile X syndromes (2014) (28)
Ultrastructural analysis of the functional domains in FMRP using primary hippocampal mouse neurons (2009) (28)
Impaired hippocampal synaptic function in secretin deficient mice (2008) (27)
Gonadal mosaicism for incontinentia pigmenti in a healthy male. (1995) (27)
Alternative splicing in the fragile X gene FMR1. (1993) (26)
The fragile X syndromes. (1995) (25)
The nature and consequences of fragile X syndrome (1995) (25)
The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice. (2015) (24)
Interspersed repetitive sequence polymerase chain reaction (IRS PCR) for generation of human DNA fragments from complex sources (1991) (24)
Genomic Comparisons of Humans and Chimpanzees (2007) (24)
Complex SNP-based haplotypes in three human helicases: implications for cancer association studies. (2002) (23)
Physical and genetic characterization reveals a pseudogene, an evolutionary junction, and unstable loci in distal Xq28. (2002) (23)
MSG1 (melanocyte-specific gene 1): mapping to chromosome Xq13.1, genomic organization, and promoter analysis. (1998) (23)
Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy (2019) (21)
Chromosome-mediated transfer of the murine Na,K-ATPase alpha subunit confers ouabain resistance (1987) (21)
CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome. (2014) (21)
Methods for finding genes. A major rate-limiting step in positional cloning. (1993) (21)
Frequent small amplifications in the FMR-1 gene in fra(X) families: limits to the diagnosis of 'premutations'. (1992) (20)
Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive function (2012) (20)
Report and abstracts of the Fourth International Workshop on Human X Chromosome Mapping 1993. St. Louis, Missouri, May 9-12, 1993. (1993) (19)
A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. (1997) (19)
Current methods for YAC clone characterization. (1990) (18)
Positional cloning reaches maturity. (1995) (16)
Intragenic probe used for diagnostics in fragile X families. (1992) (16)
The human secretin gene: fine structure in 11p15.5 and sequence variation in patients with autism. (2002) (15)
Eukaryotic chromosome transfer: linkage of the murine major histocompatibility complex to an inserted dominant selectable marker. (1984) (15)
Eucaryotic chromosome transfer: production of a murine-specific cosmid library from a neor-linked fragment of murine chromosome 17 (1986) (14)
Genetics. The critical region in trisomy 21. (2004) (14)
Metaphase chromosome transfer of introduced selectable markers. (1984) (14)
Reliability of diagnostic assessment of normal and premutation status in the fragile X syndrome using DNA testing. (1994) (13)
Regional assignment of 19 X-linked ESTs. (1993) (12)
Sixth international workshop on the fragile X and X-linked mental retardation. (1992) (11)
Applications of polymerase chain reaction methods in genome mapping. (1991) (11)
Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome (2018) (10)
Reduced mRNA for G3BP in fragile X cells: evidence of FMR1 gene regulation. (1999) (10)
PCR amplification and analysis of yeast artificial chromosomes. (1992) (9)
Report and abstracts of the Fifth International Workshop on Human X Chromosome Mapping 1994. Heidelberg, Germany, April 24-27, 1994. (1994) (8)
Cytogenetic analysis of obsessive‐compulsive disorder (OCD): Identification of a FRAXE fragile site (2003) (8)
Deletion of Fmr 1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular , EEG , and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome (2019) (8)
9th international workshop on fragile X syndrome and X-linked mental retardation. (2000) (8)
Gene replacement therapy for inborn errors of purine metabolism. (1986) (7)
Reduced mRNA for G3BP in fragile X cells: Evidence of FMR1 gene regulation (1999) (7)
Alu PCR: The Use of Repeat Sequence Primers for Amplification of Human DNA from Complex Sources (1989) (7)
Filamin (FLN1), plexin (SEX), major palmitoylated protein p55 (MPP1), and von-Hippel Lindau binding protein (VBP1) are not involved in incontinentia pigmenti type 2. (2000) (6)
Human homologue of the murine bare patches/striated gene is not mutated in incontinentia pigmenti type 2. (2000) (6)
Physical Mapping of Xq24–25 around Loci Closely Linked to the X-Linked Lymphoproliferative Syndrome Locus: An Overlapping YAC Map and Linkage between DXS12, DXS42, and DXS37 (1993) (6)
Mental Retardation and Intellectual Disability (2010) (6)
SNPs, lonkage disequilibrium, human genetic variation and Native American culture. (2001) (6)
Primate Shadow Play (2003) (6)
CHAPTER 11 – Animal Models of Fragile X Syndrome: Mice and Flies (2006) (6)
Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome (2021) (5)
De novo mutation in three families with multigenerational incontinentia pigmenti. (1994) (4)
Report of the X chromosome workshop. (1990) (4)
Human genetics. Primate shadow play. (2003) (4)
Corrigendum: Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome (1993) (4)
Genome maps III. 1992. Wall Chart. (1992) (4)
Corrigendum: Fine structure of the human FMR1 gene (Human Molecular Gentics (1993) 2 (1147-1153)) (1994) (3)
Use of Metaphase-Chromosome Transfer for Mammalian Gene Mapping (1986) (3)
Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model. (2021) (3)
Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments (2019) (3)
Direct versus indirect molecular diagnosis of fragile X mental retardation in 40 German families at risk. (1993) (3)
X-cess of variants in XLMR (2009) (2)
Chapter 2 – Fragile X Syndrome Genetics (2017) (2)
Triplet Repeat Mutations in Human Disease (1992) (2)
Mutation analysis of the DKC1 gene in incontinentia pigmenti (1999) (2)
Absence of FMR1 protein in two mentally retarded fragile X males without CGG repeat expansion (1994) (2)
SAMPLING PROPERTIES OF ESTIMATORS OF NUCLEOTIDE DIVERSITY AT DISCOVERED SNP SITES (2003) (2)
Identification of PSMB5 as a genetic modifier of fragile X–associated tremor/ataxia syndrome (2022) (1)
The large DNA insert cloning workshop. (1990) (1)
Fine structure of the human FMR1 gene. (1994) (1)
Scientific and technological synergy: Baylor College of Medicine and the Mental Retardation Research Center (2002) (1)
Simultaneous screening of the FRAXA and FRAXE loci for rapid detection of FMR1 CGG and/or AFF2 CCG repeat expansions by triplet-primed PCR. (2021) (1)
Fragile X Syndrome (1998) (1)
Overview: Fragile X syndrome (1995) (1)
Isolation of cDNA sequences around the chromosomal breakpoint in a female with lowe syndrome by direct screening of cDNA libraries with yeast artificial chromosomes (1992) (1)
The Neglected Fragile X Mutations: FRAXE and FRAXF (2006) (1)
Isolation of cDNAs from the human X chromosome and derivation of related STSs. Final progress report, April 1992--March 1995 (1995) (0)
Insights into tumor suppressor protein p53 using three‐dimensional modeling and rapid prototyping technology (2009) (0)
E. coli's Multidrug Transporter Complex: A SMART Team Exploration of Drug Resistance Mechanisms (2012) (0)
Reviewer Acknowledgment (2005) (0)
Stephen T. Warren: Human geneticist who advanced understanding of mutational mechanisms and developmental disorders (2021) (0)
Assessment of the YAC transgenic rescue of Fmr1 knockout mice Behavioral analyses (1999) (0)
A physical model of human β2‐adrenergic receptor produced by rapid prototype technology (2008) (0)
3D rapid prototyping to model DNA replication and engage students in the scientific process (2010) (0)
Primase: a SMART team adventure through DNA replication (2011) (0)
The human genome project: technology development and toolmaking (1994) (0)
The FRAXA fragile site and fragile X syndrome (2020) (0)
AGG interspersions within the FMR1 CGG repeat: Mechanisms and models of triplet repeat instability (1994) (0)
Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy (2019) (0)
Members of the fragile X gene family exhibit genetic and phenotypic interaction in mammals (2006) (0)
Fine structure of the FMR-1 locus (1994) (0)
Modeling fragile X-associated primary ovarian insufficiency (FXPOI) via ectopically expressed CGG99 repeats (2018) (0)
Mapping and ordered cloning of the human X chromosome. Progress report, September 1991--November 1992 (1992) (0)
THE RESPONSE OF NA+XH+ EXCHANGE IN ISOLATED BOVINE ARTICULAR CHONDROCYTES TO HYPERTONIC SHOCK (1995) (0)
Eukaryotic chromosome mapping: Analysis of transferred chromosome segments linked to an inserted dominant selectable marker (1985) (0)
Human X Chromosome (2000) (0)
SNPs and Functional Polymorphisms in Cancer (2005) (0)
Trinucleotide Repeat Expansions: Disorders (2006) (0)
Isolation of eDNA Sequences aroun t e Chro oso al reakpoint in a Fe ale with Lowe Syn ro e by Direct Screening of eDNA Libraries with Yeast Arti cial C ro oso es (1992) (0)
Mapping and ordered cloning of the human X chromosome (1992) (0)
Gene Family Knockout Mouse Models Fmr1 Altered Hippocampal Synaptic Plasticity in the (2015) (0)

This paper list is powered by the following services:

Other Resources About David L. Nelson

en.wikipedia.org

What Schools Are Affiliated With David L. Nelson?

David L. Nelson is affiliated with the following schools:

David L. Nelson's Academic­Influence.com Rankings